NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:57 PM
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Glucotrack Enters Purchase Agreement With Sixth Borough Capital - SEC Filing
Exclusive: Former Lockton exec Taiym joining life insurance tech firm Integrity as global COO
Brief: Glucotrack And Onetwo Analytics Present Positive Final Results Continuous Blood Glucose Monitor
Brief: Glucotrack Reports First Quarter 2025 Financial Results And Recent Corporate Highlights
Brief: Glucotrack And Onetwo Analytics To Collaborate For Clinical Study Analysis On Its Continuous Blood Glucose Monitor
Brief: Glucotrack, Inc. Announces Pricing Of $3.0 Million Public Offering
Brief: Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
Brief: Glucotrack Receives Nasdaq Notice For Bid Price Non-Compliance
Brief: Glucotrack Inc - Enters ATM Sales Agreement With Dawson James
Brief: Glucotrack, Inc. Announces Pricing Of $10.0 Million Public Offering
Brief: Glucotrack, Inc Files For Mixed Shelf Of Up To $30 Million- SEC Filing
Brief: GlucoTrack Announces New Funding For Development Of Its Continuous Blood Glucose Monitor
Brief: Glucotrack Announces The Appointment Of Andy Balo To Board Of Directors
Brief: GlucoTrack Says Glucose Monitor Has Successfully Completed 30 Days Of A 60-Day Long-Term Preclinical Study On Measuring Glucose In Epidural Space
Brief: Glucotrack Says Effective As Of October 6, 2023, Jolie Kahn Resigned As Chief Financial Officer Of Glucotrack, Inc.
Brief: Glucotrack Announces New VP Of Marketing